Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia

American Journal of Physiology - Endocrinology and Metabolism

Volumn 295, Issue 3, 2008, Pages

  Ertl, Andrew C ^a   Mann, Stephnie ^a   Richardson, Antoinette ^a   Briscoe, Vanessa J ^a   Blair, Hannah B ^a   Tate, Donna B ^a   Davis, Stephen N ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Veterans Affairs   (United States)

^c Division of Diabetes   (United States)

Author keywords

Euglycemia; Humans; Hyperinsulinemia; Hypoglycemia; Oral carbohydrate

Indexed keywords

ADRENALIN; CARBOHYDRATE; GLUCAGON; GLUCOSE; HYDROCORTISONE; NORADRENALIN; PANCREAS POLYPEPTIDE; PLACEBO; ANTIDIABETIC AGENT; INSULIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EUGLYCEMIA; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; HYPOGLYCEMIA; MALE; MUSCLE FUNCTION; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; ORANGE JUICE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPATHETIC NERVE; SYMPATHETIC TONE; SYMPTOM; SYSTOLIC BLOOD PRESSURE; ADRENERGIC SYSTEM; BLOOD; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HYPERINSULINISM; INNERVATION; METABOLISM; NEUROSECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; CARBOHYDRATES; ELECTROCARDIOGRAPHY; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HUMANS; HYDROCORTISONE; HYPERINSULINISM; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MUSCLE, SKELETAL; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; SYMPATHETIC NERVOUS SYSTEM;

EID: 53149136601     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90470.2008     Document Type: Article

References (38)

1. Abumrad NN, Rabin D, Diamond MC, Lacy WW. Use of a heated superficial hand vein as an alternative site for measurement of amino acid concentration and for the study of glucose and alanine kinetics in man. Metabolism 30: 936-940, 1981.
2. Aguilar-Parada E, Eisentraut AM, Unger R. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415-419, 1969.
3. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37: 901-917, 1988.
4. Berne C, Fagius J, Niklasson F. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest 84: 1403-1409, 1989.
5. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44: 180-184, 1995.
6. Burcelin R, Dolci W, Thorens B. Portal glucose infusion in the mouse induces hypoglycemia evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49: 1635-1642, 2000.
7. Causon R, Caruthers M, Rodnight R. Assay of plasma catecholamines by liquid chromatography with electrical detection. Annal Biochem 116: 223-226, 1982.
8. Cherrington AD, Lacy WW, Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62: 664-667, 1978.
9. Cox D, Cryer PE, Gonder-Frederick L, Clarke WL, Antain B. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care 16: 519-527, 1993.
10. Cryer PE. Glucose counterregulation: prevention and correction of hypoglycemia in humans. Am J Physiol Endocrinol Metab 264: E149-E155, 1993.
11. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46: 1328-1335, 1997.
12. Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds. Am J Physiol Endocrinol Metab 279: E1054-E1063, 2000.
13. Davis SN, Mann S, Galassetti P, Neill RA, Tate D, Ertl AC, Costa F. Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49: 1897-1903, 2000b.
14. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
15. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci Physiology 91: 2863-2867, 1994.
16. Fagius J, Berne C. The increase in sympathetic nerve activity after glucose ingestion is reduced in type I diabetes. Clin Sci (Lond) 98: 627-632, 2000.
17. Fujita S, Donovan CM. Celiac-superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 54: 3258-3264, 2005.
18. Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE, Meyer C. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 28: 1124-1131, 2005.
19. Hagopian W, Lever E, Cen D, Emmounoud D, Polonsky K, Pugh W, Moosa A, Jaspan JB. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol Endocrinol Metab 245: E171-E177, 1983.
20. Heptulla RA, Tamborlane WV, Ma TY, Rife F, Sherwin RS. Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans. J Clin Endocrinol Metab 86: 645-648, 2001.
21. Hevener AL, Bergman RN, Donovan CM. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46: 1521-1525, 1997.
22. Hevener AL, Bergman RN, Donovan CM. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 49: 8-12, 2000.
23. Hevener AL, Bergman RN, Donovan CM. Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus. Diabetes 50: 399-403, 2001.
24. Ionut V, Hucking K, Liberty IF, Bergman RN. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48: 967-975, 2005.
25. Jones KL, O'Donovan D, Russo A, Meyer JH, Stevens JE, Lei Y, Keogh J, Tonkin A, Horowitz M. Effects of drink volume and glucose load on gastric emptying and postprandial blood pressure in healthy older subjects. Am J Physiol Gastrointest Liver Physiol 289: G240-G248, 2005.
26. Levin BE. Metabolic sensing neurons and the control of energy homeostasis. Phys Behav 89: 486-489, 2006.
27. Matveyenko AV, Donovan CM. Metabolic sensors mediate hypoglycemic detection at the portal vein. Diabetes 55: 1276-1282, 2006.
28. Matveyenko AV, Bohland MA, Saberi M, Donovan CM. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia. Am J Physiol Endocrinol Metab 293: E857-E864, 2007.
29. McCrimmon RJ, Song Z, Cheng H, McNay CE, Weikart-Yeckel C, Fan X, Routh VH, Sherwin RS. Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia induced hormonal counterregulation. J Clin Invest 116: 1723-1730, 2006.
30. Moore MC, Cardin S, Edgerton DS, Farmer B, Neal DW, Lautz M, Cherrington AD. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion. Am J Physiol Endocrinol Metab 286: E226-E233, 2004.
31. Mundinger TO, Mei Q, Figlewicz DP, Lernmark Å, Taborsky GJ. Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy. Am J Physiol Endocrinol Metab 285: E1047-E1054, 2003.
32. Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87: 1239-1246, 2002.
33. Routh VH, Song Z, Liu X. The role of glucosensing neurons in the detection of hypoglycemia. Diabetes Tech Ther 6: 413-421, 2004.
34. Saberi M, Bohland M, Donovan CM. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 57: 1380-1386, 2008.
35. Smith D, Pernet A, Reid H, Bingham E, Rosenthal JM, Macdonald IA, Umpleby AM, Amiel SA. The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man. Diabetologia 45: 1416-1424, 2002.
36. Thorens B, Larsen PJ. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr Op Clin Nut Met Care 7: 471-478, 2004.
37. Wide L, Porath J. Radioimmunoassay of proteins with the use of sephadex-coupled antibodies. Biochim Biophys Acta 130: 257-260, 1966.
38. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab 285: E280-E286, 2003.